EE836 Cost-Effectiveness of Zolbetuximab Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Adenocarcinoma in Taiwan
2024 · Value in Health · 1 citations
https://doi.org/10.1016/j.jval.2024.10.1116
N
N-J. Chiang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
9
Citations
2
h-index
0
i10-index
N-J. Chiang is an academic researcher from Taipei Veterans General Hospital. The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & Pancreatic and Hepatic Oncology Research & Lung Cancer Treatments and Mutations. The author has an h-index of 2, co-authored 12 publications.
Papers by this author
worksEE674 Cost-Effectiveness of Pemigatinib for Patients With Advanced Intrahepatic Cholangiocarcinoma and FGFR2 Fusions/Rearrangements: 2024 FIGHT-202 Trial Final Results
2024 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2024.10.954
P3.12.27 Resistance Mechanisms of Novel Targeted Therapies to EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
2025 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/j.jtho.2025.09.889
332P Neoadjuvant FLOT with or without durvalumab followed by S-1–based adjuvant therapy for gastric cancer: Real-world evidence from Asia
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.10.158
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat